Neuroimmunology and Neuroinfectious Diseases

Clinical Trials and Drug Development in Neuroimmunology

This session will address the process of clinical trials and the development of new therapeutic agents for neuroimmunological and neuroinfectious diseases. It will provide an overview of trial design, regulatory considerations, patient recruitment, and ethical aspects involved in conducting clinical research. The session will highlight recent advancements in drug development, including biologics, small molecules, and targeted therapies aimed at modulating immune responses and improving neurological outcomes. Challenges such as trial endpoints, safety evaluation, and translational gaps between preclinical and clinical research will also be discussed. Additionally, the session will emphasize the importance of collaboration between academia, industry, and regulatory bodies to accelerate the development and approval of safe and effective treatments for neurological disorders.